Clinical Trials
14
Active:3
Completed:5
Trial Phases
1 Phases
Phase 3:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 3
4 (100.0%)No trials found
News
Samsung Bioepis Partners with NIPRO to Commercialize Biosimilars in Japan, Including Ustekinumab Candidate
Samsung Bioepis has entered into a strategic partnership with NIPRO Corporation for the development and commercialization of multiple biosimilar candidates in Japan, including SB17, a ustekinumab biosimilar.